Clinical translation of gene medicine. (15th July 2019)

• Record Type: Journal Article
• Authors: Wang, Fazhan; Qin, Zhou; Lu, Hansi; He, Siyan; Luo, Jing; Jin, Chaohui; Song, Xiangrong
• Other Names: Yu Haijun guestEditor.; Huang Rongqin guestEditor.; Nie Yu guestEditor.
• Is Part Of: Journal of gene medicine. Volume 21:Number 7(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-07-15
• Subjects: clinical research -- gene delivery -- gene therapy -- vector‐nonviral; Genetic transformation -- Periodicals; Gene Transfer -- Periodicals; Gene Therapy -- Periodicals; 616.042
• DOI: 10.1002/jgm.3108
• Languages: English
• ISSNs: 1099-498X

Abstract

Abstract: Gene therapy has recently witnessed accelerated progress as a new therapeutic strategy with the potential to treat a range of inherited and acquired diseases. Billions of dollars have been invested in basic and clinical research on gene medicine, with ongoing clinical trials focused on cancer, monogenic diseases, cardiovascular diseases and other refractory diseases. Advances addressing the inherent challenges of gene therapy, particularly those related to retaining the delivery efficacy and minimizing unwanted immune responses, provide the basis for the widespread clinical application of gene medicine. Several types of genes delivered by viral or non‐viral delivery vectors have demonstrated encouraging results in both animals and humans. As augmented by clinical indications, gene medicine techniques have rapidly become a promising alternative to conventional therapeutic strategies because of their better clinical benefit and lower toxicities. Their application in the clinic has been extensive as a result of the approval of many gene therapy drugs in recent years. In this review, we provide a comprehensive overview of the clinical translation of gene medicine, focusing on the key events and latest progress made regarding clinical gene therapy products. We also discuss the gene types and non‐viral materials with respect to developing gene therapeutics in clinical trials.